NCT06729151View on ClinicalTrials.gov

Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome

RecruitingOBSERVATIONAL
Enrollment

159

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Bladder Pain SyndromeFemale Sexual Dysfunction
Interventions
DRUG

Onabotulinum toxin A

Cystoscopic injection of Onabotulinum toxin A per standard clinic protocol.

BEHAVIORAL

Conservative management (dietary and behavioral)

Dietary and behavioral modifications consistent with recommendations from the American Urogynecological Society

Trial Locations (1)

20816

RECRUITING

Walter Reed National Military Medical Center, Bethesda

All Listed Sponsors
lead

Walter Reed National Military Medical Center

FED